Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Second Low-oxygen Pathway That Promotes Cell Survival In Low-oxygen Conditions Hints At Cancer, Cardiovascular Disease Physiology

  • 작성자한진
  • 작성일2006-02-26 02:39:23
  • 조회수2939
  • 첨부파일첨부파일
Article Date: 21 Feb 2006 - 9:00am (UK) Researchers at the University of Pennsylvania School of Medicine have identified a second molecular pathway that promotes cell survival in low-oxygen conditions. By teasing apart the details of cellular adaptation during oxygen deprivation, or hypoxia, the researchers hope to gain a better understanding of the abnormal hypoxic environments that are characteristic of many diseases, including solid-tumor cancers and stroke. Oxygen sensing, the ability of a cell to gauge the oxygen concentrations in its environment and to protect itself through internal regulation, is a fundamental process in most species of animals that depend entirely on oxygen to maintain cellular function. There are multiple, oxygen-dependent pathways in the cell that are regulated by changes in oxygen levels. By starving human cells of oxygen, Celeste Simon, PhD, Professor of Cell and Developmental Biology at Penn and a Howard Hughes Medical Institute (HHMI) Investigator, and colleagues discovered an oxygen-sensitive cellular pathway that leads to a decrease in protein synthesis. This finding is the second hypoxic cellular pathway to be identified by this research team. Simon, who is also a member of Penn's Abramson Cancer Center, and colleagues report their most recent findings in the February issue of Molecular Cell. In order to promote cellular adaptations to hypoxia, the cell must first recognize the presence of a low-oxygen environment. Previous genetic studies from Simon's laboratory helped to establish that the mitochondria-the energy center of the cell-play a major role in oxygen sensing. Like an alarm, mitochondria alert the cells when oxygen levels fall too low, resulting in hypoxic cells activating a protein called hypoxia-inducible factor (HIF). HIF, in turn, signals for physiological changes in nearby tissue that serve to protect oxygen-deprived cells. These changes include an increase in the number of red blood cells and blood vessels, the dilation of vessels, and changes in cell motility. "These physiological changes make biological sense," explains Simon. "The changes allow the affected cell, or tissue, to withstand the stress of low oxygen. Changes in the blood cells and vasculature enhance the ability of the blood stream to carry oxygen to the effected regions." In their most recent studies, Simon's group revealed the ability of cells to adapt to low-oxygen concentrations through a second molecular pathway. In order to protect itself during hypoxic conditions, a cell will conserve energy by greatly reducing protein synthesis. By exposing human cells to low-oxygen conditions, the researchers observed the inactivation of mTOR, a central regulator of global protein synthesis. Further genetic testing revealed that the mTOR pathway operates independent of the HIF pathway. Though paradoxical, Simon's findings suggest that the HIF pathway leads to the activation and translation of nearly 200 target genes essential to the cell's protective physiological changes, while the second and most recently discovered pathway-the mTOR pathway-inhibits protein synthesis. "The cell needs to take what energy it has to redirect to the molecular response that results in the necessary physiological changes," Simon suggests. "There is something about the messenger RNAs present in the HIF pathway that allows them to escape inhibition of global protein synthesis," Simon notes. She believes that the directions for these mRNAs to move forward and make protein, while many are left behind, lies in the genetic makeup of mRNA. Her lab is currently working to identify these molecular directions. Although hypoxic conditions exist throughout early embryonic development, the presence of hypoxic environments in adult tissue is often a response to disease. As Simon explains, "A lot of the major Western world scourges involve a decrease in oxygen availability that falls below the threshold that cells need to remain healthy and carry out their functions." Hypoxia is a prominent component of solid tumors, myocardial infarctions, stroke, diabetic retinopathy, inflammation, and atherosclerosis. In addition to hypoxia, solid cancer tumors are comprised of abnormal cells and convoluted blood vessels, which allow the tumors to resist chemotherapy and radiation treatments. New treatments for cancer are now aiming to turn off HIF and mTOR activity, halting the ability of the cell to signal its low-oxygen alert system and undergo protein synthesis. "If we are able to create a treatment for tumors by inactivating the factor that is promoting cell survival and tumor cell motility - a key regulator of tumor metastasis - we may have another option to treat solid tumors," notes Simon. Study co-authors are Liping Liu, Timothy P. Cash, Russell G. Jones, Brian Keith and Craig B. Thompson, all from the Abramson Family Cancer Research Institute (AFCRI). The research was funded by the National Institutes of Health, HHMI, and AFCRI. ### This release can be found at http://www.uphs.upenn.edu/news/ The Abramson Cancer Center of the University of Pennsylvania was established in 1973 as a center of excellence in cancer research, patient care, education and outreach. Today, the Abramson Cancer Center ranks as one of the nation's best in cancer care, according to U.S. News & World Report, and is one of the top five in National Cancer Institute (NCI) funding. It is one of only 39 NCI-designated comprehensive cancer centers in the United States. Home to one of the largest clinical and research programs in the world, the Abramson Cancer Center of the University of Pennsylvania has 275 active cancer researchers and 250 Penn physicians involved in cancer prevention, diagnosis and treatment. PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System. Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine. The University of Pennsylvania Health System comprises: its flagship hospital, the Hospital of the University of Pennsylvania, consistently rated one of the nation's "Honor Roll" hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; Penn Presbyterian Medical Center; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home health care and hospice. Contact: Karen Kreeger karen.kreeger@uphs.upenn.edu University of Pennsylvania School of Medicine
Total404 [ page1/27 ]
No. 제목 작성자 작성일 조회수
404 인제대, 과기정통부 ‘2023년도 기초연구실 지원사업’ 선정 2023.09.13 관리자 (web_admin) 2023.09.13 7
403 인제대 교수팀 '돌연사 주범 심부전 원인 규명' 2023.09.13 관리자 (web_admin) 2023.09.13 5
402 2022학년도 인제학술상 수상자 선정 결과 2023.01.05 관리자 2023.01.05 57
401 안전관리 우수연구실 인증 취득 2023.01.05 관리자 2023.01.05 40
400 한진교수 화의자의학상 수상 2023.01.05 관리자 2023.01.05 57
399 이온통로 학회 -Amy 포스터상 수상 2019.01.15 김형규 2019.01.15 2,587
398 센터 겸임교수 조성우 교수 - 한빛사 -JACC Vascular Imaging 2018.12.08 김형규 2018.12.08 2,791
397 2017 IMPACT Symposium 개최 첨부파일 2017.10.31 김보현 2017.10.31 2,588
396 경암바이오유스 2017 첨부파일 2017.08.11 김보현 2017.08.11 2,871
395 KORUS 2017 첨부파일 2017.06.21 김보현 2017.06.21 2,986
394 IMPACT 2016 심포지엄 개최 안내 첨부파일 2016.04.18 관리자 2016.04.18 4,000
393 IMPACT 2015 심포지엄 개최 안내 첨부파일 2015.04.20 서대윤 2015.04.20 2,869
392 2015 중점연구소 성과 전시회 첨부파일 2015.03.31 김형규 2015.03.31 2,462
391 Best Miso Award - 한진 2014.11.04 이정훈 2014.11.04 2,072
390 신진생리학자상 - 김형규 2014.10.29 이정훈 2014.10.29 1,816
처음이전1 2 3 4 5 6 7 8 9 10 다음 마지막